KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.88 Friday, 26th Apr 2024 PTN stock ended at $1.82. This is 5.81% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.93% from a day low at $1.68 to a day high of $1.83.
90 days $1.47 $5.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Feb 14, 2024 $4.00 $4.18 $3.96 $4.14 368 137
Feb 13, 2024 $4.00 $4.07 $3.76 $3.95 417 916
Feb 12, 2024 $4.33 $4.65 $4.10 $4.10 412 706
Feb 09, 2024 $4.07 $4.25 $3.97 $4.25 387 790
Feb 08, 2024 $4.05 $4.20 $3.72 $4.02 403 832
Feb 07, 2024 $4.20 $4.20 $3.81 $4.09 383 918
Feb 06, 2024 $4.15 $4.28 $3.90 $4.17 324 622
Feb 05, 2024 $3.80 $4.39 $3.63 $4.07 928 512
Feb 02, 2024 $3.90 $3.90 $3.33 $3.78 545 151
Feb 01, 2024 $4.29 $4.29 $3.45 $3.61 631 290
Jan 31, 2024 $5.13 $5.22 $4.13 $4.21 925 991
Jan 30, 2024 $4.96 $5.15 $4.56 $4.88 898 450
Jan 29, 2024 $4.42 $5.65 $4.37 $5.46 969 320
Jan 26, 2024 $4.01 $4.40 $3.83 $4.38 427 983
Jan 25, 2024 $3.90 $4.00 $3.65 $4.00 227 873
Jan 24, 2024 $3.87 $4.01 $3.60 $3.82 300 440
Jan 23, 2024 $3.71 $3.90 $3.51 $3.81 238 211
Jan 22, 2024 $3.70 $4.07 $3.45 $3.67 800 484
Jan 19, 2024 $2.95 $3.72 $2.95 $3.68 698 586
Jan 18, 2024 $2.94 $2.97 $2.77 $2.92 227 065
Jan 17, 2024 $2.95 $2.99 $2.80 $2.92 194 322
Jan 16, 2024 $2.94 $3.05 $2.85 $2.88 199 285
Jan 12, 2024 $2.83 $2.93 $2.71 $2.80 237 719
Jan 11, 2024 $2.90 $2.95 $2.64 $2.77 218 974
Jan 10, 2024 $2.95 $3.15 $2.80 $2.85 114 734
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT